NCT07399626 Adaptation and Validation of the Hypomanic Personality Scale (HPS-6) to Romanian
| NCT ID | NCT07399626 |
| Status | Recruiting |
| Phase | Phase 1, Phase 2 |
| Sponsor | Babes-Bolyai University |
| Condition | Bipolar Disorder (BD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-09-22 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 50 participants in total. It began in 2025-09-22 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The HPS-6 (Hypomanic Personality Scale, 6 item version) could prove to be a valuable candidate for screening measures of high risk individuals. In the following study, we aim to validate and adapt the HPS-6 for the Romanian population.
Eligibility Criteria
Inclusion Criteria: * 18-50 years of age * Not at high risk of suicide (current) * Not high SUDs / AUDs (current) * Native Romanian speaker * Cognitive abilities intact (reading comprehension of items) Exclusion Criteria: * High risk of suicide (current) * High SUDs / AUDs (current)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07399626 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Bipolar Disorder (BD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07399626 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT07399626 currently recruiting?
Yes, NCT07399626 is actively recruiting participants. Contact the research team at renata.gheorghiu@ubbcluj.ro for enrollment information.
Where is the NCT07399626 trial being conducted?
This trial is being conducted at Cluj-Napoca, Romania.
Who is sponsoring the NCT07399626 clinical trial?
NCT07399626 is sponsored by Babes-Bolyai University. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.